Author： Steen V.D.
Publisher： Adis International
ISSN： 1175-0561
Source： American Journal of Clinical Dermatology, Vol.2, Iss.5, 2001-05, pp. : 315-325
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis
By McGeer Edith G. McGeer Patrick L.
BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. :
Phosphodiesterase Type 4 Inhibitors: Potential in the Treatment of Multiple Sclerosis?
By Dinter H.
BioDrugs, Vol. 13, Iss. 2, 2000-02 ,pp. :
Treatment of Multiple Sclerosis with the Interferon- s: Comparative Risks and Benefits
By Herndon R.M.
BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. :